"Klinische Studien"

During the past decade, ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH" are "Cardiovascular Disease" (2 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH" in a lesser frequency.

Most popular intervention types in "ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Empagliflozin" (1 trials), "linagliptin" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH" are 4 trials for "All" genders.

Currently, there are NaN active trials in "ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".